Safety and Efficacy Study of the Combined Ablation Procedure to Treat Paroxysmal Atrial Fibrillation
| Status: | Archived |
|---|---|
| Conditions: | Atrial Fibrillation |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | March 2010 |
| End Date: | March 2013 |
Feasibility Study For Safety and Efficacy Evaluation Of The Combined Ablation Procedure For The Treatment Of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
This is a multi-center, prospective, open label, feasibility clinical study,evaluating the
safety and efficacy of the combined ablation procedure for the treatment of symptomatic
paroxysmal atrial fibrillation.
The purpose of this feasibility study is to evaluate the safety and efficacy of the
epicardial / endocardial combined procedure for the treatment of drug refractory symptomatic
Paroxysmal Atrial Fibrillation (AF) patients, using the nContact Numeris®-AF Guided
Coagulation System with VisiTrax® epicardially and the Biosense Webster NaviStar®
ThermoCool® Diagnostic/Ablation deflectable Tip Catheter in conjunction with the Carto
Navigation System endocardially.
We found this trial at
2
sites
Click here to add this to my saved trials
Click here to add this to my saved trials